The Customs-Trade Partnership Against Terrorism (C-TPAT) is a voluntary supply chain security program led by U.S. Customs and Border Protection (CBP). It is intended to improve the security of supply chains of private enterprises against the threat of terrorism.
In this webinar, we will provide an overview of the Customs and Trade Partnership Against Terrorism and how to participate and achieve compliance. Our expert speaker Ms. Carolyn Troiano will provide an industry best practice related to C-TPAT compliance, also different strategies for reducing the cost and complexity of ensuring with C-TPAT.
At the end of this presentation, attendees will be able to learn:
- Understanding of the C-TPAT program, compliance and benefits of joining the program
- Industry best practices related to C-TPAT compliance
- Develop a standard approach to complying with the voluntary C-TPAT guidelines.
- Strategies for reducing the cost and complexity of compliance with C-TPAT
Area Covered In The Session:
- Customs and Trade Partnership Against Terrorism (C-TPAT)
- “Tiered” strategy
- Program guidelines and highlights
- C-TPAT compliance
- US Customs Border Protection (CBP)
- Civil Penalties
- Criminal Penalties
- C-TPAT Partners
- C-TPAT Partnership
- C-TPAT Partnership Benefits
- Building a C-TPAT Program
- Best Practices
- Common Pitfalls
- Supply Chain Management and Analysts
- Information Technology Analysts
- QC/QA Managers
- QC/QA Analysts
- Regulatory Affairs Analysts
- Legal Professionals in Manufacturing Companies
- Clinical Data Managers
- Clinical Data Scientists
- Analytical Chemists
- Compliance Managers
- Transportation Personnel
- Security Personnel responsible for supply-chain
- Auditors and Inspectors responsible for supply-chain management
About Our Speaker:
Carolyn Troiano has more than 35 years of experience in computer system validation and compliance in the pharmaceutical, medical device, tobacco and other FDA-regulated industries. She is currently an independent consultant, advising companies on computer system validation and large-scale IT system implementation projects.
During her career, Carolyn worked directly, or on a consulting basis, for many of the larger pharmaceutical companies in the US and Europe, where she developed validation programs and strategies. She collaborated with FDA and other industry representatives on 21 CFR Part 11, the FDA’s electronic record/electronic signature regulation.